Nisa Investment Advisors
PCVX icon

Nisa Investment Advisors’s Vaxcyte PCVX Stock Holding History

Nisa Investment Advisors’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
3,980
+110
+3% +$5.97K ﹤0.01% 1203
2026
Q1 		$225K Buy
3,870
+756
+24% +$41K ﹤0.01% 1176
2025
Q4 		$144K Sell
3,114
-140
-4% -$6.26K ﹤0.01% 1320
2025
Q3 		$117K Buy
3,254
+1,596
+96% +$52.9K ﹤0.01% 1385
2025
Q2 		$53.9K Sell
1,658
-1,319
-44% -$43.2K ﹤0.01% 1569
2025
Q1 		$112K Buy
2,977
+293
+11% +$23.4K ﹤0.01% 1366
2024
Q4 		$220K Buy
2,684
+475
+22% +$47.2K ﹤0.01% 1268
2024
Q3 		$252K Buy
2,209
+110
+5% +$9.91K ﹤0.01% 1223
2024
Q2 		$158K Buy
2,099
+825
+65% +$56.2K ﹤0.01% 1369
2024
Q1 		$87K Buy
1,274
+85
+7% +$5.89K ﹤0.01% 1508
2023
Q4 		$74.7K Sell
1,189
-1,192
-50% -$61.9K ﹤0.01% 1523
2023
Q3 		$121K Hold
2,381
– – ﹤0.01% 1446
2023
Q2 		$119K Buy
2,381
+669
+39% +$31.7K ﹤0.01% 1467
2023
Q1 		$64K Sell
1,712
-54,940
-97% -$2.33M ﹤0.01% 1639
2022
Q4 		$2.72M Buy
56,652
+55,820
+6,709% +$2.19M 0.02% 638
2022
Q3 		$35K Buy
832
+41
+5% +$1.04K ﹤0.01% 1875
2022
Q2 		$17K Sell
791
-739
-48% -$17.1K ﹤0.01% 2085
2022
Q1 		$37K Hold
1,530
– – ﹤0.01% 1920
2021
Q4 		$29K Buy
+1,530
New +$35.6K ﹤0.01% 1859

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Nisa Investment Advisors's PCVX Position: Q2 2026 in Review

Nisa Investment Advisors increased its Vaxcyte (PCVX) stake by 2.8% in Q2 2026, buying an estimated $5.97K and bringing the position to 3,980 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1203.

Nisa Investment Advisors first reported a position in PCVX in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.72M in Q4 2022. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Nisa Investment Advisors held 3,980 shares of Vaxcyte worth $231K as of Q2 2026.
  • Nisa Investment Advisors bought 110 Vaxcyte shares in Q2 2026, an estimated $5.97K.
  • Vaxcyte made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1203 holding.
  • Nisa Investment Advisors first reported a position in Vaxcyte in Q4 2021 and has held it in 19 quarters since.
  • Nisa Investment Advisors's Vaxcyte position peaked at $2.72M in Q4 2022.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.